Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine.

Literature DB >> 4675488

Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine.

G M Besser, L Parke, C R Edwards, I A Forsyth, A S McNeilly.

Abstract

In five patients with inappropriate lactation and amenorrhoea or impotence brom-ergocryptine was found to suppress the lactation and to diminish the raised plasma prolactin levels. The responses to treatment suggest that there may be an inverse relationship between prolactin secretion and gonadotrophin secretion in man.

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 1972 PMID： 4675488 PMCID： PMC1786102 DOI： 10.1136/bmj.3.5828.669

Source DB: PubMed Journal: Br Med J ISSN： 0007-1447

21 in total

1. Thyrotrophin-releasing hormone as a thyroid-function test.

Authors: B J Ormston; R J Cryer; R Garry; G M Besser; R Hall
Journal: Lancet Date: 1971-07-03 Impact factor: 79.321

2. Effects of melatonin and serotonin on the release of FSH and prolactin.

Authors: I A Kamberi; R S Mical; J C Porter
Journal: Endocrinology Date: 1971-06 Impact factor: 4.736

3. Treatment of non-puerperal galactorrhoea with an ergot alkaloid.

Authors: P M Lutterbeck; J S Pryor; L Varga; R Wenner
Journal: Br Med J Date: 1971-07-24

4. Levodopa suppression of prolactin in nonpuerperal galactorrhea.

Authors: W B Malarkey; L S Jacobs; W H Daughaday
Journal: N Engl J Med Date: 1971-11-18 Impact factor: 91.245

5. Evidence for a luteolytic function of prolactin in the intact cyclic rat using 2-Br-alpha-Ergokryptine (CB 154).

Authors: E Billeter; E Flückinger
Journal: Experientia Date: 1971-04-15

6. Effects of ergocornine and 2-Br-alpha-ergokryptin (CB-154) on the formation of mammary hyperplastic alveolar nodules and the pituitary prolactin levels in mice.

Authors: R Yanai; H Nagasawa
Journal: Experientia Date: 1970-06-15

7. [2-Br-alpha-ergokryptin: influence on fertility and lactation in the rat].

Authors: E Flückiger; H R Wagner
Journal: Experientia Date: 1968-11-15

8. [Inhibition of prolactin secretion by ergocornine and 2-Br-alpha-ergocryptine: direct action on the hypophysis in culture].

Authors: J L Pasteels; A Danguy; M Frérotte; F Ectors
Journal: Ann Endocrinol (Paris) Date: 1971 Jan-Feb Impact factor: 2.478

9. Pituitary portal vessel infusion of hypothalamic extract and release of LH, FSH and prolactin.

Authors: I A Kamberi; R S Mical; J C Porter
Journal: Endocrinology Date: 1971-06 Impact factor: 4.736

10. Plasma prolactin activity in inappropriate lactation.

Authors: I A Forsyth; G M Besser; C R Edwards; L Francis; R P Myres
Journal: Br Med J Date: 1971-07-24

47 in total

1. Development of pituitary adenoma treatment--a critical essay.

Authors: A M Landolt
Journal: Pituitary Date: 1999-08 Impact factor: 4.107

2. An abnormality of oestrogen feedback in amenorrhoea-galactorrhoea.

Authors: M R Glass; R W Shaw; W R Butt; R L Edwards; D R London
Journal: Br Med J Date: 1975-08-02

3. The "top 50": a perspective on the BMJ drawn from the Science Citation Index.

Authors: B Dixon
Journal: BMJ Date: 1990-10-03

4. Amenorrhœa and galactorrhœa.

Authors: C J Dewhurst
Journal: Proc R Soc Med Date: 1973-06

5. Disorders of prolactin secretion.

Authors: M O Thorner
Journal: J Clin Pathol Suppl (Assoc Clin Pathol) Date: 1976

6. The history of the treatment of pituitary adenomas.

Authors: Nicholas F Maartens
Journal: Endocrine Date: 2005-10 Impact factor: 3.633

7. Present status of neurosurgery in the treatment of prolactinomas.

Authors: R Fahlbusch; M Buchfelder
Journal: Neurosurg Rev Date: 1985 Impact factor: 3.042

8. Serum prolactin and progesterone concentrations in ovulatory infertility.

Authors: T Ranta; P Lehtovirta; U H Stenman; M Seppälä
Journal: J Endocrinol Invest Date: 1979 Jan-Mar Impact factor: 4.256

9. Dopamine agonists and analogues have an antiproliferative effect on CHO-K1 cells.

Authors: R Maggio; M Armogida; M Scarselli; F Salvadori; B Longoni; C Pardini; A Chiarenza; S Chiacchio; F Vaglini; R Bernardini; A Colzi; G U Corsini
Journal: Neurotox Res Date: 2000-04 Impact factor: 3.911

10. Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy.

Authors: H J Künzig; W Geiger; K D Schulz; K H Lose
Journal: Arch Gynakol Date: 1975